Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€39.40

€39.40

-0.510%
-0.2
-0.510%
-
 
24.04.24 / Frankfurt WKN: 897505 / Symbol: TARO / Name: Taro Pharm / Stock / Pharmaceuticals / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Taro Pharmaceutical Industries Ltd Stock

Taro Pharmaceutical Industries Ltd shows a slight decrease today, losing -€0.200 (-0.510%) compared to yesterday.

Pros and Cons of Taro Pharmaceutical Industries Ltd in the next few years

Pros
?
S********** s********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Taro Pharmaceutical Industries Ltd vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Taro Pharmaceutical Industries Ltd -0.510% 0.508% 2.062% 80.000% 5.319% -36.640% -57.810%
Opko Health Inc. -0.050% -0.982% 29.393% -16.662% -19.340% -68.292% -43.684%
Catalent Inc. -0.230% -0.343% 1.260% 28.378% 26.820% -45.000% 52.155%
Repligen Corp. -1.120% 3.910% -14.690% 3.022% -6.444% -13.082% -

Comments

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Ratings data for TARO provided by MarketBeat
Show more

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Ratings data for TARO provided by MarketBeat
Show more

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Ratings data for TARO provided by MarketBeat
Show more